ProShare Advisors LLC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$52,000
-18.8%
10,090
-2.9%
0.00%
Q2 2019$64,000
-22.9%
10,392
-11.2%
0.00%
Q1 2019$83,000
-16.2%
11,704
+0.8%
0.00%
-100.0%
Q4 2018$99,000
-64.1%
11,611
-15.7%
0.00%
-50.0%
Q3 2018$276,000
-25.0%
13,777
-3.2%
0.00%0.0%
Q2 2018$368,000
+5.4%
14,235
-2.4%
0.00%0.0%
Q1 2018$349,000
-28.9%
14,591
+0.7%
0.00%
-33.3%
Q4 2017$491,000
+69.3%
14,490
+5.9%
0.00%0.0%
Q3 2017$290,000
+30.0%
13,689
+7.2%
0.00%
+50.0%
Q2 2017$223,000
-7.5%
12,771
-7.3%
0.00%
-33.3%
Q1 2017$241,000
-17.2%
13,781
-19.9%
0.00%0.0%
Q4 2016$291,000
+14.6%
17,205
+11.2%
0.00%
-25.0%
Q3 2016$254,000
-7.6%
15,466
-14.7%
0.00%0.0%
Q2 2016$275,000
+9.6%
18,138
+4.6%
0.00%
+33.3%
Q1 2016$251,000
-45.7%
17,344
+6.2%
0.00%
-50.0%
Q4 2015$462,00016,3270.01%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,601,351$43,963,0009.03%
Granite Point Capital Management, L.P. 256,031$4,327,0003.45%
Opaleye Management Inc. 285,000$4,817,0002.84%
Brenner West Capital Advisors 1,221,463$20,643,0002.28%
ARMISTICE CAPITAL, LLC 536,000$9,058,0002.14%
NEXTHERA CAPITAL LP 151,670$2,563,0001.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 185,234$3,130,0001.41%
Cheyne Capital Management (UK) LLP 144,765$2,448,0001.38%
SPHERA FUNDS MANAGEMENT LTD. 270,000$4,563,0001.16%
Mosaic Family Wealth, LLC 123,314$2,084,0000.96%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders